Abstract
Hypertension and hyperlipidemia are two main causes of cardiovascular diseases with rapidly increasing pervasiveness worldwide. Complimentary alternative medicines provide an effective choice to these highly prevalent global health issues. Nigella sativa has diverse range of traditional and pharmacological potential with established safety profile. This study was carried out in 163 mild-moderate hypertensive and hyperlipidemic patients. Patients were selected randomly of both genders. The patient's age ranges between 20-65 years. This clinical study was conducted to evaluate the clinical effect of Nigella sativa virgin oil in hypertension and hyperlipidemic patients of the selected region and also assess its antioxidative potential. The results conferred that N. sativa has significant (< 0.05) effect on controlling hypertension and hyperlipidemia as compared to standards used. Moreover, N. sativa conferred excellent antioxidant potential as compared to other commercially available edible oils.